Related Experiment Video
Updated: Feb 10, 2026

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
Wolbachia wStri Blocks Zika Virus Growth at Two Independent Stages of Viral Replication
M J Schultz1,2,3, A L Tan4, C N Gray4
1Department of Biology, Boston University, Boston, Massachusetts, USA.
Abstract:
Mosquito-transmitted viruses are spread globally and present a great risk to human health. Among the many approaches investigated to limit the diseases caused by these viruses are attempts to make mosquitos resistant to virus infection. Coinfection of mosquitos with the bacterium Wolbachia pipientis from supergroup A is a recent strategy employed to reduce the capacity for major vectors in the Aedes mosquito genus to transmit viruses, including dengue virus (DENV), Chikungunya virus (CHIKV), and Zika virus (ZIKV). Recently, a supergroup B Wolbachia wStri, isolated from Laodelphax striatellus, was shown to inhibit multiple lineages of ZIKV in Aedes albopictus cells. Here, we show that wStri blocks the growth of positive-sense RNA viruses DENV, CHIKV, ZIKV, and yellow fever virus by greater than 99.9%. wStri presence did not affect the growth of the negative-sense RNA viruses LaCrosse virus or vesicular stomatitis virus. Investigation of the stages of the ZIKV life cycle inhibited by wStri identified two distinct blocks in viral replication. We found a reduction of ZIKV entry into wStri-infected cells. This was partially rescued by the addition of a cholesterol-lipid supplement. Independent of entry, transfected viral genome was unable to replicate in Wolbachia-infected cells. RNA transfection and metabolic labeling studies suggested that this replication defect is at the level of RNA translation, where we saw a 66% reduction in mosquito protein synthesis in wStri-infected cells. This study's findings increase the potential for application of wStri to block additional arboviruses and also identify specific blocks in viral infection caused by Wolbachia coinfection.IMPORTANCE Dengue, Zika, and yellow fever viruses are mosquito-transmitted diseases that have spread throughout the world, causing millions of infections and thousands of deaths each year. Existing programs that seek to contain these diseases through elimination of the mosquito population have so far failed, making it crucial to explore new ways of limiting the spread of these viruses. Here, we show that introduction of an insect symbiont, Wolbachia wStri, into mosquito cells is highly effective at reducing yellow fever virus, dengue virus, Zika virus, and Chikungunya virus production. Reduction of virus replication was attributable to decreases in entry and a strong block of virus gene expression at the translational level. These findings expand the potential use of Wolbachia wStri to block viruses and identify two separate steps for limiting virus replication in mosquitos that could be targeted via microbes or other means as an antiviral strategy.
Insights
The bacterium Wolbachia wStri significantly reduces the replication of mosquito-borne viruses like dengue, Zika, and yellow fever by over 99.9%. This insect symbiont blocks viral entry and translation, offering a new strategy against arboviruses.
Area of Science:
- Microbiology and Virology
- Vector-borne disease control
Background:
- Mosquito-transmitted viruses (e.g., dengue, Zika, yellow fever) pose a global health risk.
- Current mosquito control methods are insufficient, necessitating novel strategies.
- Wolbachia pipientis coinfection is an emerging approach to limit arbovirus transmission.
Purpose of the Study:
- To evaluate the efficacy of supergroup B Wolbachia wStri against multiple arboviruses.
- To identify the mechanisms by which wStri inhibits viral replication in mosquito cells.
Main Methods:
- Infection of Aedes albopictus cells with Wolbachia wStri.
- Quantification of viral RNA replication for positive-sense (DENV, CHIKV, ZIKV, YFV) and negative-sense (LaCrosse, VSV) viruses.
- Investigation of ZIKV life cycle stages affected by wStri, including viral entry and replication, using RNA transfection and metabolic labeling.
Main Results:
- Wolbachia wStri inhibited the growth of DENV, CHIKV, ZIKV, and YFV by over 99.9%.
- wStri did not affect negative-sense RNA viruses.
- Two replication blocks were identified: reduced ZIKV entry (partially rescued by cholesterol-lipid supplement) and impaired viral genome replication at the translational level, evidenced by a 66% reduction in mosquito protein synthesis.
Conclusions:
- Wolbachia wStri demonstrates broad efficacy against major positive-sense RNA arboviruses.
- The dual mechanism of inhibiting viral entry and translation presents a potent antiviral strategy.
- wStri offers expanded potential for controlling arboviruses beyond existing Wolbachia applications.
Related Concept Videos
Viral Replication: Lysogenic Cycle
Viral Replication: Lytic Cycle
What are Viruses?
Viral Recombination
Viral Structure
Viral Mutations

